Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome
Anthony M. Vandersteen(Izaak Walton Killam Health Centre), Timothy J. Aitman(Institute of Genetics and Cancer), Christina Kanonidou(NHS Greater Glasgow and Clyde), David Parry(AstraZeneca (United Kingdom)), Rebecca Darlay(Newcastle University), Javier Santoyo‐López, Jana Vandrovcová(Texas Tech University), Marion Bartlett(London North West Healthcare NHS Trust), Alison Meynert(Institute of Genetics and Cancer), Heather J. Cordell(Newcastle University), Neeti Ghali(Ghent University Hospital), Ruwan Weerakkody(Imperial College London), Daniel J Toddie-Moore(Edinburgh Cancer Research), Fleur S. van Dijk(London North West Healthcare NHS Trust), Carole Cummings(London North West Healthcare NHS Trust), Rodney Grahame(University College London Hospitals NHS Foundation Trust), F M Pope, Angela F. Brady(Northwick Park Hospital), Hanadi Kazkaz(Creighton University)
Cited by 11
Related Papers
The 2017 international classification of the Ehlers–Danlos syndromes
|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2017|1.9k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Ensembl 2012
|Nucleic Acids Research|2011|839
Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences
|Briefings in Bioinformatics|2016|815
International nosology of heritable disorders of connective tissue, Berlin, 1986
|American Journal of Medical Genetics|1988|733